NCT00127101 2015-04-21An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)Merck Sharp & Dohme LLCPhase 1 Terminated23 enrolled 13 charts